Of a total number of four candidates, we selected PTPN12 for a further experiment and validation because it has previously been shown to play an important role in breast cancer initiation and progression [40,41], which is similar to the role of the Hippo pathway in breast cancer [17,19]. Here, PTPN12 is linked to breast carcinoma.